21 CFR Part 524 - OPHTHALMIC AND TOPICAL DOSAGE FORM NEW ANIMAL DRUGS

  1. § 524.86 Amitraz.
  2. § 524.154 Bacitracin, neomycin, and polymyxin B ophthalmic ointment.
  3. § 524.155 Bacitracin, neomycin, polymyxin B, and hydrocortisone ophthalmic ointment.
  4. § 524.390 Chloramphenicol ophthalmic ointment.
  5. § 524.402 Chlorhexidine.
  6. § 524.450 Clotrimazole.
  7. § 524.463 Copper naphthenate.
  8. § 524.575 Cyclosporine ophthalmic ointment.
  9. § 524.590 Diclofenac.
  10. § 524.660 Dimethyl sulfoxide.
  11. § 524.770 Doramectin.
  12. § 524.775 Emodepside and praziquantel.
  13. § 524.802 Enrofloxacin and silver sulfadiazine otic emulsion.
  14. § 524.814 Eprinomectin.
  15. § 524.815 Eprinomectin and praziquantel.
  16. § 524.900 Famphur.
  17. § 524.920 Fenthion.
  18. § 524.955 Florfenicol, terbinafine, and betamethasone acetate otic gel.
  19. § 524.957 Florfenicol, terbinafine, and mometasone otic solution.
  20. § 524.960 Flumethasone, neomycin, and polymyxin B ophthalmic solution.
  21. § 524.970 Flunixin.
  22. Fluocinolone Topical and Otic Dosage Forms (§§ 524.981 - 524.2620)
    1. § 524.981 [Reserved]
    2. § 524.981a Fluocinolone cream.
    3. § 524.981b Fluocinolone solution.
    4. § 524.981c Fluocinolone and neomycin cream.
    5. § 524.981d Fluocinolone and dimethyl sulfoxide solution.
    6. § 524.981e Fluocinolone and dimethyl sulfoxide otic solution.
    7. § 524.998 Fluralaner.
    8. § 524.1001 Furalaner and moxidectin.
    9. § 524.1005 Furazolidone powder.
    10. § 524.1044 Gentamicin ophthalmic and topical dosage forms.
    11. § 524.1044a Gentamicin ophthalmic solution.
    12. § 524.1044b Gentamicin and betamethasone otic solution.
    13. § 524.1044c Gentamicin ophthalmic ointment.
    14. § 524.1044d Gentamicin and betamethasone ointment.
    15. § 524.1044e Gentamicin spray.
    16. § 524.1044f Gentamicin and betamethasone spray.
    17. § 524.1044g Gentamicin, betamethasone, and clotrimazole ointment.
    18. § 524.1044h Gentamicin, mometasone, and clotrimazole otic suspension.
    19. § 524.1044i Gentamicin and betamethasone ophthalmic solution.
    20. § 524.1132 Hydrocortisone, miconazole, and gentamicin otic suspension.
    21. § 524.1140 Imidacloprid and ivermectin.
    22. § 524.1146 Imidacloprid and moxidectin.
    23. § 524.1193 Ivermectin topical solution.
    24. § 524.1195 Ivermectin otic suspension.
    25. § 524.1200 Kanamycin ophthalmic and topical dosage forms.
    26. § 524.1200a Kanamycin ophthalmic ointment.
    27. § 524.1200b Kanamycin ophthalmic solution.
    28. § 524.1204 Kanamycin, amphomycin, and hydrocortisone ointment.
    29. § 524.1240 Levamisole.
    30. § 524.1376 2-Mercaptobenzothiazole solution.
    31. § 524.1443 Miconazole.
    32. § 524.1445 Miconazole, polymixin B, and prednisolone suspension.
    33. § 524.1446 Milbemycin otic solution.
    34. § 524.1448 Mirtazapine transdermal ointment.
    35. § 524.1450 Moxidectin.
    36. § 524.1465 Mupirocin.
    37. § 524.1484 Neomycin ophthalmic and topical dosage forms.
    38. § 524.1484b Neomycin, isoflupredone, tetracaine, and myristyl-gamma-picolinium powder.
    39. § 524.1484c Neomycin, isoflupredone, and tetracaine ointment.
    40. § 524.1484d Neomycin, hydrocortisone, and tetracaine otic ointment.
    41. § 524.1484e Neomycin and polymyxin B ophthalmic solution.
    42. § 524.1484f Neomycin, prednisolone, and tetracaine otic suspension.
    43. § 524.1484g Neomycin, thiabendazole, and dexamethasone solution.
    44. § 524.1484h Neomycin, penicillin, polymyxin B, and hydrocortisone suspension.
    45. § 524.1484i Neomycin and hydrocortisone ointment.
    46. § 524.1484j Neomycin and prednisolone ophthalmic ointment.
    47. § 524.1484k Neomycin and prednisolone suspension.
    48. § 524.1580 Nitrofurazone topical dosage forms.
    49. § 524.1580a Nitrofurazone ointment.
    50. § 524.1580b Nitrofurazone soluble powder.
    51. § 524.1580c Nitrofurazone and butacaine ointment.
    52. § 524.1600 Nystatin ophthalmic and topical dosage forms.
    53. § 524.1600a Nystatin, neomycin, thiostrepton, and triamcinolone ointment.
    54. § 524.1600b Nystatin, neomycin, thiostrepton, and triamcinolone ophthalmic ointment.
    55. § 524.1610 Orbifloxacin, mometasone furoate monohydrate, and posaconazole suspension.
    56. § 524.1662 Oxytetracycline ophthalmic and topical dosage forms.
    57. § 524.1662a Oxytetracycline and hydrocortisone spray.
    58. § 524.1662b Oxytetracycline and polymyxin B ophthalmic ointment.
    59. § 524.1742 Phosmet emulsifiable liquid.
    60. § 524.1982 Proparacaine ophthalmic solution.
    61. § 524.2098 Selamectin.
    62. § 524.2099 Selamectin and sarolaner.
    63. § 524.2101 Selenium disulfide suspension.
    64. § 524.2350 Tolnaftate cream.
    65. § 524.2482 Triamcinolone spray.
    66. § 524.2483 Triamcinolone cream.
    67. § 524.2620 Liquid crystalline trypsin, Peru balsam, castor oil.
Authority:
Source:
40 FR 13873, Mar. 27, 1975, unless otherwise noted.
{'United States Code': [{'Title': '21', 'Section': '360b', 'headtext': ' New animal drugs', 'cleanpath': '/uscode/text/21/360b'}], 'Statutes at Large': [], 'Public Laws': [], 'Presidential Documents': []}